Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 19.55 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 6:00 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

vivo bio tech ltd (VIVO) Snapshot

Open
19.55
Previous Close
19.55
Day High
19.55
Day Low
19.55
52 Week High
08/6/15 - 19.55
52 Week Low
12/29/14 - 16.55
Market Cap
182.8M
Average Volume 10 Days
0.0
EPS TTM
0.50
Shares Outstanding
9.4M
EX-Date
12/4/95
P/E TM
39.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for VIVO BIO TECH LTD (VIVO)

Related News

No related news articles were found.

vivo bio tech ltd (VIVO) Related Businessweek News

No Related Businessweek News Found

vivo bio tech ltd (VIVO) Details

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical, biotech, and agri companies worldwide. The company offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, and pharmacokinetic and toxicokinetic studies. Its biologic research services include molecular biology services, mutation screening by growth promotion tests, process development and scale-up of recombinant proteins, protein purification and characterization, cell based assay development, stability studies, raising polyclonal antibodies and purification, and method development and validation for biologics. The company offers in-vitro services and screening programs, such as AMES, micronucleus, chromosomal aberration, neutral red uptake, oxidative DNA damage, and SHE cell transformation assay, as well as various in-vitro ADME services to support drug development program. It also provides in-vivo services, including preclinical testing services in rodents/non-rodents, and canines for the evaluation of toxicity, pharmacological properties, and ADME and PK properties of drug candidates in early stage development process. In addition, Vivo Bio Tech Limited is involved in pathogen screening of various specimens; and in-house breeding of specific pathogen free rodents. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Secunderabad, India.

Founded in 1987

vivo bio tech ltd (VIVO) Top Compensated Officers

Chief Executive Office and Whole Time Directo...
Total Annual Compensation: 3.0M
Whole Time Director, Member of Audit Committe...
Total Annual Compensation: 183.7K
Test Facility Manager
Total Annual Compensation: 150.0K
Compensation as of Fiscal Year 2014.

vivo bio tech ltd (VIVO) Key Developments

Vivo Bio Tech Ltd. to Report Fiscal Year 2015 Results on Aug 31, 2015

Vivo Bio Tech Ltd. announced that they will report fiscal year 2015 results on Aug 31, 2015

Vivo Bio Tech Ltd., Board Meeting, Aug 31, 2015

Vivo Bio Tech Ltd., Board Meeting, Aug 31, 2015., at 11:00 Indian Standard Time. Agenda: To take note on auditor’s report on annual accounts for the financial year ending March 31, 2015; to approve draft director’s report for the financial year ending March 31, 2015; to fix date, time and place of annual general meeting; to take note of secretarial audit report issued by Mr. N.V.S.S. Suryanarayana Rao, company secretary in practice; to approve draft notice of AGM of the company; to fix record date/closure of register of members; to approve appointment of N.V.S.S. Suryanarayana Rao, company secretary in practice as scrutinizer for conducting E-voting; and to consider any other matter with permission of chairman.

Vivo Bio Tech Ltd. Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2015

Vivo Bio Tech Ltd. reported unaudited earnings results for the first quarter ended June 30, 2015. For the quarter, net sales/income from operation was INR 60.522 million against INR 36.664 million a year ago. Profit from operation before other income, finance cost and exceptional items was INR 4.011 million against loss from operation before other income, finance cost and exceptional items of INR 2.545 million a year ago. Profit from ordinary activities before tax was INR 4.840 million against loss from ordinary activities before tax of INR 1.310 million a year ago. Net profit was INR 3.388 million or INR 0.36 per basic and diluted share against net loss of INR 1.310 million or INR 0.14 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIVO:IN 19.55 INR 0.00

VIVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Vimta Labs Ltd 65.60 INR 0.00
View Industry Companies
 

Industry Analysis

VIVO

Industry Average

Valuation VIVO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVO BIO TECH LTD, please visit www.vivobio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.